Your Cart ( 4 Items )

• Emerging Oral Immunomodulators for the Treatment of Psoriasis: A Review of Phase III Clinical Trials for Apremilast and Tofacitinib
  August 2015 | Volume 14 | Issue 8 | Original Article | 786 | Copyright © August 2015
  Rachel McAndrew MD,^a,b Ethan Levin MD,^b and John Koo MD^b
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis?
  February 2018 | Volume 17 | Issue 2 | Original Article | 175 | Copyright © February 2018
  Boni E. Elewski MD,^a Wendy Cantrell DNP CRNP,^a and Tina Lin PharmD^b
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Washington Whispers
  February 2003 | Volume 2 | Issue 1 | Features | 89 | Copyright © February 2003
  
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Cutaneous Adverse Events Associated With GLP-1 Receptor Agonists: A FAERS Database Analysis From 2018-2024
  January 2026 | Volume 25 | Issue 1 | Original Article | 11 | Copyright © January 2026
  Marisa N. Fat BS^a, Hayden C. Johnson BA MQE^b, Aaron S. Farberg MD^c,d,e
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs